PortfoliosLab logoPortfoliosLab logo
EW vs. MCHP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EW vs. MCHP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and Microchip Technology Incorporated (MCHP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EW achieves a -0.16% return, which is significantly lower than MCHP's 51.10% return. Over the past 10 years, EW has underperformed MCHP with an annualized return of 9.72%, while MCHP has yielded a comparatively higher 15.99% annualized return.


EW

1D
-0.76%
1M
4.58%
YTD
-0.16%
6M
2.44%
1Y
13.25%
3Y*
-0.88%
5Y*
-3.17%
10Y*
9.72%

MCHP

1D
2.47%
1M
1.99%
YTD
51.10%
6M
43.32%
1Y
48.83%
3Y*
6.19%
5Y*
6.57%
10Y*
15.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EW vs. MCHP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EW
Edwards Lifesciences Corporation
-0.16%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%
MCHP
Microchip Technology Incorporated
51.10%14.61%-34.96%30.90%-17.98%27.49%33.73%48.02%-16.71%39.46%

Correlation

The correlation between EW and MCHP is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.36

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2000

0.30

The correlation between EW and MCHP shifts across timeframes, from 0.18 (1 year) to 0.36 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

EW:

$1.87

MCHP:

$0.43

PE Ratio

EW:

45.49

MCHP:

221.70

PEG Ratio

EW:

1.46

MCHP:

3.34

PS Ratio

EW:

7.89

MCHP:

8.20

Total Revenue (TTM)

EW:

$6.30B

MCHP:

$4.71B

Gross Profit (TTM)

EW:

$4.92B

MCHP:

$2.72B

EBITDA (TTM)

EW:

$1.44B

MCHP:

$1.02B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EW vs. MCHP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EW
EW Risk / Return Rank: 5959
Overall Rank
EW Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
EW Sortino Ratio Rank: 5454
Sortino Ratio Rank
EW Omega Ratio Rank: 5151
Omega Ratio Rank
EW Calmar Ratio Rank: 6363
Calmar Ratio Rank
EW Martin Ratio Rank: 6565
Martin Ratio Rank

MCHP
MCHP Risk / Return Rank: 7171
Overall Rank
MCHP Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
MCHP Sortino Ratio Rank: 7272
Sortino Ratio Rank
MCHP Omega Ratio Rank: 6969
Omega Ratio Rank
MCHP Calmar Ratio Rank: 6868
Calmar Ratio Rank
MCHP Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EW vs. MCHP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Microchip Technology Incorporated (MCHP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWMCHPDifference
Sharpe ratioReturn per unit of total volatility

-0.50

Sortino ratioReturn per unit of downside risk

-0.79

Omega ratioGain probability vs. loss probability

1.11

1.20

-0.10

Calmar ratioReturn relative to maximum drawdown

0.96

1.28

-0.33

Martin ratioReturn relative to average drawdown

2.37

3.40

-1.03

EW vs. MCHP - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.51, which is lower than the MCHP Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of EW and MCHP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EW vs. MCHP - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum MCHP drawdown of -63.77%. Use the drawdown chart below to compare losses from any high point for EW and MCHP.


Loading charts...

Drawdown Indicators


EWMCHPDifference

Max Drawdown

Largest peak-to-trough decline

-54.32%

-63.77%

+9.45%

Max Drawdown (1Y)

Largest decline over 1 year

-12.73%

-34.41%

+21.68%

Max Drawdown (3Y)

Largest decline over 3 years

-37.53%

-63.77%

+26.24%

Max Drawdown (5Y)

Largest decline over 5 years

-54.32%

-63.77%

+9.45%

Max Drawdown (10Y)

Largest decline over 10 years

-54.32%

-63.77%

+9.45%

Current Drawdown

Current decline from peak

-34.87%

-7.00%

-27.87%

Average Drawdown

Average peak-to-trough decline

-14.48%

-16.71%

+2.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.15%

12.99%

-7.84%

Volatility

EW vs. MCHP - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 6.36%, while Microchip Technology Incorporated (MCHP) has a volatility of 16.18%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than MCHP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWMCHPDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.36%

16.18%

-9.82%

Volatility (6M)

Calculated over the trailing 6-month period

18.73%

32.33%

-13.60%

Volatility (1Y)

Calculated over the trailing 1-year period

24.12%

44.05%

-19.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.60%

44.17%

-11.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.25%

41.91%

-9.66%

Dividends

EW vs. MCHP - Dividend Comparison

EW has not paid dividends to shareholders, while MCHP's dividend yield for the trailing twelve months is around 1.91%.


PositionTTM20252024202320222021202020192018201720162015
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MCHP
Microchip Technology Incorporated
1.91%2.86%3.16%1.76%1.65%0.98%1.07%1.40%2.02%1.65%2.24%3.07%

Financials

EW vs. MCHP - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Microchip Technology Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.20B1.40B1.60B1.80B2.00B2.20B20222023202420252026
1.65B
1.31B
(EW) Total Revenue
(MCHP) Total Revenue
Values in USD except per share items

EW vs. MCHP - Profitability Comparison

The chart below illustrates the profitability comparison between Edwards Lifesciences Corporation and Microchip Technology Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20222023202420252026
78.2%
73.8%
Portfolio components
EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.

MCHP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a gross profit of 967.30M and revenue of 1.31B. Therefore, the gross margin over that period was 73.8%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.

MCHP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported an operating income of 211.10M and revenue of 1.31B, resulting in an operating margin of 16.1%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.

MCHP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a net income of 116.40M and revenue of 1.31B, resulting in a net margin of 8.9%.


Frequently Asked Questions


EW and MCHP have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MCHP has higher volatility (16.18%) compared to EW (6.36%). In terms of maximum drawdown, EW dropped -54.32% vs MCHP's -63.77%.

MCHP currently has the higher Sharpe Ratio (1.01 vs 0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EW and MCHP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer